# Multimodal Treatment Strategy for Cancer Cachexia

> **NCT00625742** · NA · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 15 (actual)

## Conditions studied

- Advanced Cancer
- Cachexia

## Interventions

- **BEHAVIORAL:** Graded Resistance Training
- **BEHAVIORAL:** Aerobic Exercise
- **DRUG:** Melatonin
- **DIETARY_SUPPLEMENT:** Juven
- **DRUG:** Atenolol
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT00625742
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2016-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00625742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00625742, "Multimodal Treatment Strategy for Cancer Cachexia". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00625742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*